PTP LAR expression compared to prognostic indices in metastatic and non-metastatic breast cancer

Charles M. LeVea, Carl T. McGary, Javelle R. Symons, Robert A. Mooney

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

Several prognostic indices in breast cancer, including c-erbB2, epithelial growth factor receptors (EGFR), estrogen and progesterone receptors are signal transduction molecules. Recently, expression of another signal transduction molecule, the protein tyrosine phosphatase LAR, has been suggested to be increased in breast cancer. The objective of the current investigation was to examine the relationship between LAR expression and prognostic parameters in breast cancer. LAR expression was associated with metastatic potential in the well-characterized 13762NF rat mammary adenocarcinoma clones. The metastatic MTLn3 and MTLn2 clones expressed sizable amounts of LAR. The essentially non-metastatic MTC clone had little LAR expression. C-erbB2 had highest expression in the highly metastatic MTLn3 clone, but c-erbB2 levels were sizeable in the weakly metastatic MTLn2 and non-metastatic MTC clone. EGFR expression had the strongest association with a clone's metastatic potential, being very high in MTLn3, weak in MTLn2, and undetectable in MTC. In human breast cancer specimens, LAR expression was strongly positive in 50% of metastatic cases but in only 21% of 'non-metastatic' cases. As with the 13762NF-derived clones, c-erbB2 expression was strongly positive independent of metastatic phenotype. However, 46% (6/13) of cases that were strongly positive for c-erbB2 were strongly positive for LAR. Only 17% (2/11) of negative or weakly c-erbB2 positive samples were strongly positive for LAR. All ER+ positive tumors (n = 15) were positive for LAR and 53% of these tumors were strongly positive for LAR. In ER- negative cases, only 1 of 11 was strongly positive for LAR. While the current data indicate a strong association between ER and LAR expression in breast cancer tissue (p = 0.003), additional studies are warranted to further explore the relationship between LAR and prognostic indices of breast cancer progression.

Original languageEnglish (US)
Article number280273
Pages (from-to)221-228
Number of pages8
JournalBreast Cancer Research and Treatment
Volume64
Issue number2
DOIs
StatePublished - Jan 1 2000

Keywords

  • 13762NF tumor
  • Breast cancer
  • EGF receptor
  • Estrogen receptor
  • LAR
  • Tyrosine phosphatase
  • erbB2

Fingerprint

Dive into the research topics of 'PTP LAR expression compared to prognostic indices in metastatic and non-metastatic breast cancer'. Together they form a unique fingerprint.

Cite this